QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using Omicsoft and Ingenuity Pathway Analysis

September 15, 2022
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with user and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you will learn how to:
· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, a specific disease/disease subtype and more)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Exploring bevacizumab response in low-grade glioma

92 views August 31, 2022

See how Dr, Nilson from QIAGEN Digital Insights navigates an interesting...

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

287 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Inflammatory Bowel Disease: Drug Target and Biomarker Investigation using QIAGEN OmicSoft

143 views June 01, 2022

In this 90-minute training using Inflammatory Bowel Disease (IBD) public data...


Systems analysis of cancer cell lines for drug target discovery

138 views April 25, 2022

Cancer cell line models have been a cornerstone of cancer research for...